Skip to main content

Advertisement

Table 1 Clinical characteristics of the patients

From: Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer

Characteristics Total (n = 87)
Age at Diagnosis (years)  
Median (range) 54 (29–74)
Average (SEM) 53 (1.0)
Age categories  
< 50 years 30 (35%)
≥ 50 years 57 (65%)
Primary surgery  
Mastectomy 48 (55%)
Lumpectomy 39 (45%)
Histological type  
Ductal 79 (90%)
Lobular 5 (6%)
Other 3 (4%)
Histological grade  
SBR I 12 (14%)
SBR II 47 (54%)
SBR III 28 (32%)
Tumor size  
T1 11 (13%)
T2 63 (72%)
T3 13 (15%)
Nb. positive nodes  
1–3 55 (63%)
≥ 4 32 (37%)
ER status (IHC)  
positive 83 (96%)
negative 4 (4%)
PR status (IHC)  
positive 80 (92%)
negative 7 (8%)
Cancer-provoked death  
Yes 22 (26%)
No 65 (74%)
Metastasis-relapse  
Yes 30 (35%)
No 57 (65%)
  1. Abbreviations: ER, estrogen receptor; PR, progesterone receptor; IHC, immunohistochemistry; SBR, Scarff Bloom and Richardson.